Literature DB >> 16816330

Cytoplasmic polyadenylation controls cdc25B mRNA translation in rat oocytes resuming meiosis.

Eran Gershon1, Dalia Galiani, Nava Dekel.   

Abstract

Resumption of meiosis in oocytes represents the entry into M-phase of the cell cycle and is regulated by the maturation-promoting factor (MPF). Activation of MPF is catalyzed by the dual specificity phosphatase, cdc25. In mammals, cdc25 is represented by a multigene family consisting of three isoforms: A, B and C. A recent report that female mice lacking cdc25B exhibit impaired fertility suggests a role for this isoform in regulating the G2- to M-transition in mammalian oocytes. Supporting the above-mentioned observation, we demonstrate herein that microinjection of neutralizing antibodies against cdc25B interfered with the ability of rat oocytes to undergo germinal vesicle breakdown (GVB). We also show accumulation of cdc25B in GVB oocytes and a transient reduction in its amount at metaphase I of meiosis. The accumulation of cdc25B was associated with its mRNA cytoplasmatic polyadenylation and was prevented by the protein synthesis inhibitor cyclohexamide as well as by the polyadenylation inhibitor cordycepin. Immunofluorescence staining revealed translocation of cdc25B to the metaphase II spindle apparatus. Taken together, our findings provide evidence that cdc25B is involved in resumption of meiosis in rat oocytes. We further demonstrate for the first time, a periodic accumulation of cdc25B throughout meiosis that is translationally regulated and involves cdc25B mRNA polyadenylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816330     DOI: 10.1530/rep.1.01093

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  8 in total

1.  Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice.

Authors:  Weixing Shen; Faiyaz Ahmad; Steven Hockman; John Ma; Hitoshi Omi; Nalini Raghavachari; Vincent Manganiello
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

2.  High cGMP and low PDE3A activity are associated with oocyte meiotic incompetence.

Authors:  Eran Gershon; Iris Maimon; Dalia Galiani; Michal Elbaz; Sharon Karasenti; Nava Dekel
Journal:  Cell Cycle       Date:  2019-08-12       Impact factor: 4.534

Review 3.  Oocyte maturation failure: a syndrome of bad eggs.

Authors:  Stephanie Beall; Carol Brenner; James Segars
Journal:  Fertil Steril       Date:  2010-04-07       Impact factor: 7.329

4.  LSD1 is essential for oocyte meiotic progression by regulating CDC25B expression in mice.

Authors:  Jeesun Kim; Anup Kumar Singh; Yoko Takata; Kevin Lin; Jianjun Shen; Yue Lu; Marc A Kerenyi; Stuart H Orkin; Taiping Chen
Journal:  Nat Commun       Date:  2015-12-02       Impact factor: 14.919

Review 5.  Newly Identified Regulators of Ovarian Folliculogenesis and Ovulation.

Authors:  Eran Gershon; Nava Dekel
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

Review 6.  A Systematic Review of the Biological Effects of Cordycepin.

Authors:  Masar Radhi; Sadaf Ashraf; Steven Lawrence; Asta Arendt Tranholm; Peter Arthur David Wellham; Abdul Hafeez; Ammar Sabah Khamis; Robert Thomas; Daniel McWilliams; Cornelia Huiberdina de Moor
Journal:  Molecules       Date:  2021-09-28       Impact factor: 4.411

Review 7.  Signaling mechanisms and their regulation during in vivo or in vitro maturation of mammalian oocytes.

Authors:  Patrycja Strączyńska; Krzysztof Papis; Emilia Morawiec; Michał Czerwiński; Zdzisław Gajewski; Anita Olejek; Anna Bednarska-Czerwińska
Journal:  Reprod Biol Endocrinol       Date:  2022-02-24       Impact factor: 5.211

8.  A tudor domain protein SPINDLIN1 interacts with the mRNA-binding protein SERBP1 and is involved in mouse oocyte meiotic resumption.

Authors:  Ting Gang Chew; Anne Peaston; Ai Khim Lim; Chanchao Lorthongpanich; Barbara B Knowles; Davor Solter
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.